Looking to lead a stronger, healthier life?
Sign up for our Wellness Wire newsletter for all sorts of nutrition, fitness, and wellness wisdom.

Now we’re in this together.
Thanks for subscribing and having us along on your health and wellness journey.

See all Healthline's newsletters »
It's a Type 2 Life
It's a Type 2 Life

San Francisco Bay Area resident Patrick Totty writes about his experiences living with type 2 diabetes

See all posts »

My Pill Is Not My Savior

I’m lucky enough to have hooked up with a great endocrinologist who happens to be one of the people pharmaceutical companies rely on for Phase III trails of their anti-diabetes drugs. (Phase III trials are the last step before drugs go to the Food and Drug Administration for final marketing approval.)

Over the last four years, he’s involved me in three drug trials, including one for a drug that was very much like Byetta. Byetta is the diabetes drug that caused a sensation when it was introduced in 2005 because one of its happy side effects was sometimes dramatic weight loss.

I didn’t lose any weight on the Byetta analog, I suspect because I was on placebo. Although that was disappointing, I was consoled by the fact that I was receiving regular check-ups and consultations from a very intelligent, humorous, and well-read man, and getting paid a small stipend to boot.

Currently I’m testing dapagliflozin, a once-daily oral drug that works by shunting glucose to the kidneys and the urine stream, bypassing the digestive system. By directing some of my glucose intake away from my bloodstream, where it can cause damage, the drug reduces the wear and tear of diabetes on my body. The only side effect seems to be an extra trip or two to the bathroom each day.  

A very pleasant bonus is that the drug also seems to be helping me lose some weight. Not a lot, but, still, noticeable—perhaps 4 lbs. over the past month. I mentioned this to my endocrinologist the last time I was in for a routine follow-up, and it prompted him to deliver a bit of wisdom: “This is great news that this drug is helping you lose weight. But never let a pill become your savior or the source of your weight loss.”

He went on to explain that the old prescription of diet and exercise would apply to me until the day (may it be far, far off) I die. “Never depend on a drug to do what you should be doing for yourself.” He said this to me affectionately and sweetly, but also with a tone that told me he was speaking to me from years of experience.

I’ve been thinking about what he said in the days since I last saw him. My dapagliflozin, which I will be on only through June, is kind of like those rockets they attach to a jet that needs help taking off from a very short runway. They give a great initial boost, but once the plane is airborne, it must rely on its own engines to cover the rest of the distance.

Time for me to head out and walk a couple of miles.



  • 1

Tags: Drugs , Science , Insights

Was this article helpful? Yes No

Recommended for You

  • Goodbye, Farewell, Adieu

    By: Patrick Totty
    Nov 15, 2012

    This is my last Healthline blog. When I started blogging here in April, I had serious concerns about posting twice a week. There’s only so much you can say about type 2, I thought. But several months and 60-odd blog entries later, it turns...

    Read more »

  • Do Sulfonylureas Add to Cardiovascular Risks?

    By: Patrick Totty
    Nov 13, 2012

    One of the challenges to having type 2 is trying to stay abreast of new research about the disease. That’s why routinely checking out sites like Healthline on the Internet can be a big help when it comes to talking to your doctor or endocrinolo...

    Read more »

  • Tomorrow Belongs to Us

    By: Patrick Totty
    Nov 08, 2012

    Every one of us who has diabetes, and the people who love us, hope for the day when science finds a way to cure our disease. Not just kick it into remission, but cure. In the meantime, until that great day, it’s good to remember just how ...

    Read more »

  • Small A1c Drop, Big Life Expectancy Gain

    By: Patrick Totty
    Nov 01, 2012

    While controversy swirls around what A1c percentage is ideal for type 2s, no one denies that lower is better. Currently, the recommended A1c target is 6.5%, equivalent to a daily average of140 mg/dL. For older people who’ve been diagnosed for...

    Read more »


About the Author

Bay Area resident Patrick Totty was diagnosed with type 2 diabetes in July, 2003.

Recent Blog Posts